Press Releases

Emmes Introduces Telehealth Capabilities into Advantage eClinical

Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS

Takara Bio Inc. has announced that it has entered into a License Agreement with non-profit/charity organization, Telethon.

X-Chem and Structural Genomics Consortium Enter Into Collaboration to Unlock the Human Proteome and Promote Open Science

X-Chem, a global leader in innovative drug discovery services, and the Structural Genomics Consortium (SGC), a public-private partnership dedicated to accelerating drug discovery through open science, announced that they have entered a collaboration aimed at creating new chemical tools to study human proteins.

Tower Cold Chain Accelerates Growth with Two New Senior Appointments for The Americas

Following the opening of its new Centre of Excellence facility to support further growth across the Americas, advanced temperature-controlled container specialist, Tower Cold Chain, has continued the expansion of its global team with the appointment of two senior leaders.

DNAnexus-enabled UK Biobank Research Analysis Platform Surpasses 5,000 Users in Two Years

The DNAnexus-enabled UK Biobank Research Analysis Platform community has grown to more than 5,000 users around the world.

Alder Therapeutics set to redefine cell therapy development

Alder Therapeutics is set to reshape the cell therapy sector with a novel, reduced-risk approach to cell therapy development and two promising cell therapy candidates for diseases with high unmet need.

Creative Proteomics Leads the Way with Cutting-Edge RNA Pull Down Service

Creative Proteomics Introduces Mature Solutions for Membrane Protein Identification

Evecxia Therapeutics and Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treatment

Creative Proteomics Launches State-of-the-Art Peptide Sequencing Service to Advance Proteomics Research

Cytel continues expansion of market access and medical communication capabilities with the acquisition of co.faktor

Cytel Inc. has acquired the Berlin-based company co.faktor GmbH.

Discovery Park selects 13 start-ups to join Discovery Spark life science programme

Thirteen life science start-ups have been accepted onto Discovery Park’s new business support programme and competition, Discovery Spark. The eight-week Discovery Spark programme will equip the early-stage companies with the necessary skills to catalyse their business growth plans and gives them the chance to win a business support package worth over £100,000.

Announcing Kivo GO: An intuitive DMS to accelerate speed-to-market for life sciences

Kivo today introduced Kivo GO, a unified platform for emerging life sciences teams who need to work together efficiently across all functions while maintaining compliance and security.

Sygnature Discovery successfully identifies potent SHP2 degrader compounds in collaboration with UBE Corporation

Creative Biostructure Announces New Method for Producing CRAL-TRIO Domain-Containing Proteins Using Virus-Like Particles

Creative Enzymes Launches Diamine Oxidase (Food-Grade) for Enhanced Food Safety and Digestive Health

CD Genomics Redefines RNA Sequencing with Revolutionary Ultra Low RNA Sequencing Technology

Creative Enzymes Unveils Custom Blends Product Line for Bioprocessing Solutions

CD Genomics Unveils Cutting-Edge DNA 6mA Sequencing Service for Epigenomic Research

Macleaya cordata Extract and Analysis Service Now Available at Lifeasible